Surfactant status and respiratory outcome in premature infants receiving late surfactant treatment-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Surfactant status and respiratory outcome in premature infants receiving late surfactant treatment

Published:2018-08-15 Issue:3 Volume:85 Page:305-311
ISSN:0031-3998
Container-title:Pediatric Research
language:en
Short-container-title:Pediatr Res

Author:

Ballard Philip L., ,Keller Roberta L.,Truog William E.,Chapin Cheryl,Horneman Hart,Segal Mark R.,Ballard Roberta A

Publisher

Springer Science and Business Media LLC

Subject

Pediatrics, Perinatology, and Child Health

Link

http://www.nature.com/articles/s41390-018-0144-3.pdf

Reference40 articles.

1. Ehrenkranz, R. A. et al. Validation of the National Institutes of Health consensus definition of bronchopulmonary dysplasia. Pediatrics 116, 1353–1360 (2005).

2. Natarajan, G. et al. Outcomes of extremely low birth weight infants with bronchopulmonary dysplasia: impact of the physiologic definition. Early Hum. Dev. 88, 509–515 (2012).

3. Jobe, A. H. & Bancalari, E. Bronchopulmonary dysplasia. Am. J. Respir. Crit. Care Med. 163, 1723–1729 (2001).

4. Coalson, J. J. Pathology of new bronchopulmonary dysplasia. Semin. Neonatol. 8, 73–81 (2003).

5. Gibson, A. M. et al. Lung function in adult survivors of very low birth weight, with and without bronchopulmonary dysplasia. Pediatr. Pulmonol. 50, 987–994 (2015).

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. mRNA therapies: Pioneering a new era in rare genetic disease treatment;Journal of Controlled Release;2024-05

2. Emerging role of metabolic reprogramming in hyperoxia-associated neonatal diseases;Redox Biology;2023-10

3. Insights Gained Into the Treatment of COVID19 by Pulmonary Surfactant and Its Components;Frontiers in Immunology;2022-05-03

4. Metabolic dysregulation in bronchopulmonary dysplasia: Implications for identification of biomarkers and therapeutic approaches;Redox Biology;2021-12

5. The Role of Pulmonary Surfactants in the Treatment of Acute Respiratory Distress Syndrome in COVID-19;Frontiers in Pharmacology;2021-06-29

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3